Q3 2025 · 13F-HR
Rosalind Advisors, Inc.holdings as filed
Filed 2025-11-13 · accession 0001622627-25-000038
$292.6M
Reported value
39
Positions
2025-09-30
Period end
The Brief · Rosalind Advisors, Inc. · Q3 2025
AI · grounded in 13F
Rosalind Advisors, Inc. established a new position in DCTH valued at $33.0M. The fund also initiated new stakes in CYTK for $22.0M and FENC for $19.4M. Additional new positions include VSTM, RZLT, and XERS. The fund ended the period with 39 positions and total AUM of $292.6M.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 24661P807 | DCTH | DELCATH SYS INC | $33.0M | 11.3% | 3,300,389 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $22.0M | 7.51% | 400,000 | Common | SOLE |
| 31447P100 | FENC | FENNEC PHARMACEUTICALS INC | $19.4M | 6.64% | 2,076,840 | Common | SOLE |
| 92337C203 | VSTM | VERASTEM INC | $17.0M | 5.82% | 1,929,563 | Common | SOLE |
| 76200L309 | RZLT | REZOLUTE INC | $17.0M | 5.81% | 1,807,202 | Common | SOLE |
| 98422E103 | XERS | XERIS BIOPHARMA HOLDINGS INC | $14.6M | 5.00% | 1,795,766 | Common | SOLE |
| 805111101 | SVRA | SAVARA INC | $14.3M | 4.88% | 4,000,000 | Common | SOLE |
| M68830112 | MDWD | MEDIWOUND LTD | $13.5M | 4.61% | 749,054 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $12.9M | 4.43% | 600,000 | Common | SOLE |
| 156944100 | CGON | CG ONCOLOGY INC | $12.1M | 4.13% | 300,000 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $10.7M | 3.65% | 100,000 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $9.5M | 3.26% | 350,000 | Common | SOLE |
| 45779A846 | NSPR | INSPIREMD INC | $9.4M | 3.22% | 3,905,743 | Common | SOLE |
| 30233G209 | EYPT | EYEPOINT PHARMACEUTICALS INC | $9.3M | 3.16% | 650,000 | Common | SOLE |
| 60255C885 | BRD1EUR | MIND MEDICINE MINDMED INC | $8.8M | 3.02% | 750,000 | Common | SOLE |
| 23256X407 | HELP | CYBIN INC | $8.8M | 3.02% | 1,500,000 | Common | SOLE |
| 35168W103 | GUTS | FRACTYL HEALTH INC | $8.0M | 2.72% | 5,000,000 | Common | SOLE |
| 002120202 | ATYR | ATYR PHARMA INC | $7.6M | 2.59% | 1,039,080 | Common | SOLE |
| N90064101 | QURE | UNIQURE NV | $7.3M | 2.49% | 125,000 | Common | SOLE |
| 98420X202 | XFOR | X4 PHARMACEUTICALS INC | $5.3M | 1.81% | 1,544,607 | Common | SOLE |
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $4.7M | 1.60% | 400,000 | Common | SOLE |
| 002120952 | ATYR | ATYR PHARMA INC | $4.5M | 1.53% | 1,570,200 | PUT | SOLE |
| 00444T209 | TLPH | TALPHERA INC | $3.9M | 1.34% | 4,385,757 | Common | SOLE |
| 74319B502 | PROF | PROFOUND MED CORP | $3.4M | 1.16% | 692,185 | Common | SOLE |
| 62857J201 | MYO | MYOMO INC | $3.4M | 1.16% | 3,790,788 | Common | SOLE |
| M8001Q126 | PYPD | POLYPID LTD | $3.1M | 1.05% | 918,668 | Common | SOLE |
| 46090E953 | QQQ | INVESCO QQQ TR | $1.6M | 0.53% | 250,000 | PUT | SOLE |
| 09077D209 | BFRI | BIOFRONTERA INC | $1.1M | 0.38% | 1,140,764 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $1.1M | 0.38% | 1,542,520 | Common | SOLE |
| 78464A950 | — | SPDR SERIES TRUST | $950,638 | 0.32% | 2,128,300 | PUT | SOLE |
| 89532M101 | TRVI | TREVI THERAPEUTICS INC | $915,000 | 0.31% | 100,000 | Common | SOLE |
| 92337C903 | VSTM | VERASTEM INC | $898,215 | 0.31% | 646,500 | CALL | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC | $885,000 | 0.30% | 100,000 | Common | SOLE |
| 78462F953 | SPY | SPDR S&P 500 ETF TR | $717,500 | 0.25% | 300,000 | PUT | SOLE |
| 76200L909 | RZLT | REZOLUTE INC | $546,360 | 0.19% | 263,100 | CALL | SOLE |
| 45166A902 | IDYA | IDEAYA BIOSCIENCES INC | $236,940 | 0.08% | 35,900 | CALL | SOLE |
| 76029N906 | REPL | REPLIMUNE GROUP INC | $183,100 | 0.06% | 511,400 | CALL | SOLE |
| 464287955 | — | ISHARES TR | $20,000 | 0.01% | 200,000 | PUT | SOLE |
| 80706P953 | SRRK | SCHOLAR ROCK HLDG CORP | $10,000 | 0.00% | 100,000 | PUT | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.